HMHeewon Ma

Heewon Ma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Heewon Ma has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison of inhalation anesthesia and total intravenous anesthesia in patients undergoing laparoscopic cholecystectomy

    by Ji Yong Yeom, Do Hyun Lee, Jinkyung Kim, Heewon Ma, Eun Kyung Choi

    Background: The choice of anesthetic technique may influence perioperative stability and postoperative recovery. This study compared postoperative recovery between sevoflurane inhalational anesthesia and propofol-based total intravenous anesthesia (TIVA) in patients undergoing laparoscopic cholecystectomy. Methods: In this prospective, randomized clinical trial, 81 patients were assigned to receive either sevoflurane inhalational anesthesia (Group S, n = 40) or propofol-based TIVA (Group T, n = 41). The primary outcome was postoperative recovery quality assessed using the Quality of Recovery-15 (QoR-15) questionnaire preoperatively and 24 hours after surgery. Secondary outcomes included postoperative pain, rescue analgesic requirement, incidence of postoperative nausea and vomiting, intraoperative remifentanil consumption, and perioperative hemodynamic variables. Results: No statistically significant between-group difference was detected in QoR-15 scores at 24 hours postoperatively (unadjusted mean difference [TIVA minus sevoflurane], 2.39 points; 95% confidence interval [CI], −4.83 to 9.61; P = .512). After adjustment for preoperative QoR-15 scores, the difference remained statistically nonsignificant (adjusted mean difference, 0.78 points; 95% CI, −5.91 to 7.47; P = .817). Postoperative pain scores and postoperative nausea and vomiting incidence did not differ significantly between groups. However, the proportion of patients requiring rescue analgesics at 6 hours postoperatively was lower in the TIVA group (9.8% vs 30.0%; unadjusted P = .027). Intraoperative remifentanil consumption was significantly higher in the TIVA group ( P < .001). Heart rate at postanesthesia care unit arrival and mean blood pressure after intubation were lower in the TIVA group (adjusted P < .05). Conclusion: No statistically significant difference in postoperative recovery quality at 24 hours was detected between propofol-based TIVA and sevoflurane anesthesia. Although rescue analgesic requirements at 6 hours were lower in the TIVA group, this secondary finding should be interpreted cautiously. The CI for the primary outcome did not exclude clinically meaningful differences; therefore, these findings do not establish equivalence between the 2 anesthetic techniques.

  • Open Access

    Effect of nefopam on postoperative catheter-related bladder discomfort after transurethral resection of the bladder under general anesthesia: A randomized controlled trial

    by Ji Yong Yeom, Yeong Uk Kim, Jinkyung Kim, Juhee Min, Heewon Ma, Eunkyung Choi

    Objective: Catheter-related bladder discomfort is a common complication following transurethral resection of bladder tumor and may impair postoperative recovery. This study evaluated the effect of intraoperative nefopam on catheter-related bladder discomfort and postoperative recovery quality. Methods: In this prospective, randomized, double-blind trial, patients undergoing transurethral resection of bladder tumor under general anesthesia were allocated to either Group N (nefopam, 20 mg) or Group S (normal saline). Catheter-related bladder discomfort was assessed using a 4-point scale at multiple postoperative time points. Catheter-related bladder discomfort was defined based on a score ≥1, and moderate-to-severe catheter-related bladder discomfort was defined based on a score ≥2. Postoperative recovery quality was evaluated using the Quality of Recovery 15 questionnaire. Results: In total, 72 patients were analyzed. The cumulative incidence of catheter-related bladder discomfort (score ≥1) was 80.6% in Group N and 94.4% in Group S (risk difference, −13.9%; 95% confidence interval, −30.0% to 2.0%; p = 0.076). Longitudinal analysis of catheter-related bladder discomfort severity revealed significant time and group × time interaction effects (both p < 0.001), with lower odds of greater catheter-related bladder discomfort severity in Group N during the early postoperative period. Moderate-to-severe catheter-related bladder discomfort (score ≥2) occurred in 16.7% of the patients in Group N and 58.3% of those in Group S (risk difference, −41.7%; 95% confidence interval, −58.6% to −19.5%; odds ratio, 0.14; 95% confidence interval, 0.05–0.43; p < 0.001). The Quality of Recovery 15 score at 24 h was higher in Group N than in Group S (133.5 ± 11.25 vs. 124.3 ± 14.1; mean difference, 9.2 points; 95% confidence interval, 3.2–15.2; p = 0.003). Conclusions: Intraoperative nefopam did not significantly reduce the cumulative incidence of catheter-related bladder discomfort; however, it was associated with lower early postoperative catheter-related bladder discomfort severity and a lower incidence of moderate-to-severe catheter-related bladder discomfort. Quality of Recovery 15 scores at 24 h were also higher in the nefopam group. Registration: This study was registered with the Clinical Research Information Service (https://cris.nih.go.kr/, KCT0011457)